President Donald Trump said Iran may have seized two tankers in the Strait of Hormuz Friday, after Iran's Revolutionary Guard says it seized one and there were news reports of...World Newsread more
Amazon hires Trump-allied lobbyist Jeff Miller as battle for Pentagon contract heats up.Politicsread more
In a series of tweets, the president addressed an unusual controversy stemming from a speech delivered Thursday by New York Fed President John Williams.Marketsread more
More than a quarter of the S&P 500 companies report earnings in the week ahead, and that could buffet the market as investors await the Fed's meeting at the end of the month.Market Insiderread more
Companies aren't waiting for the U.S.-China trade war to be resolved, says the head of the world's biggest money manager.Investingread more
Executives from United Airlines and American Airlines were "shocked" that state-owned airline Qatar Airways CEO Akbar Al Baker was also invited to the meeting, according to a...Airlinesread more
Earlier this week, a lawyer said Jeffrey Epstein, a former friend of Presidents Donald Trump and Bill Clinton, had "improper sexual contact" with at least one woman under the...Politicsread more
Walmart is making further organizational changes as it continues to integrate its store and digital operations and leadership, according to a memo obtained by CNBC that was...Retailread more
George Nader helped arrange a January 2017 meeting in the Seychelles between Erik Prince and the head of Russia's sovereign wealth fund, who reported directly to Vladimir...Politicsread more
These are the stocks posting the largest moves midday.Market Insiderread more
"I'm not hearing people blame the Fed as much as they're blaming tariffs," says CNBC's Jim Cramer.US Economyread more
Theranos said it has settled lawsuits with one of its biggest backers.
The blood-testing start-up said on Monday it had reached a confidential settlement with hedge fund Partner Fund Management, which invested more than $96 million in Theranos in 2014.
Partner Fund Management had accused Theranos of securities fraud, alleging that the company had attracted the investment '[t]hrough a series of lies, material
The fund declined to comment to CNBC.
Theranos has come under fire over the past few years, after Wall Street Journal investigations questioned the efficacy of its blood testing technology, raising flags for regulators. But Theranos has now resolved proceedings with the , as well as the Arizona Attorney General.
The resolution of these disputes means that founder Elizabeth Holmes can move forward with a plan to surrender some of her stake in the company, according to a press release by the company. The Journal had previously reported the stock tender, noting that in exchange for receiving extra shares, shareholders were to agree not to sue the company.
Holmes plans to give away shares to the "most significant shareholders," almost all of whom agreed to participate in the deal, Theranos' statement said. It was not clear whether investors had agreed not to sue as part of the arrangement.
"Theranos is pleased to have resolved both lawsuits with PFM. Although we are confident that we would have prevailed at trial, resolution of these two cases allows our tender offer to go forward and enables us to return our focus where it belongs, which is on executing our business plans and delivering value for our shareholders," Theranos general counsel David Taylor said in a a statement.
Watch: Theranos founder giving away shares to avoid lawsuits